Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Peter S KirkKehao ZhuYingye ZhengLisa F NewcombJeannette M SchenkJames D BrooksPeter R CarrollAtreya DashWilliam J EllisChristopher Paul FilsonMartin E GleaveMichael LissFrances MartinJesse K McKenneyTodd M MorganPeter S NelsonIan M ThompsonAndrew A WagnerDaniel W LinJohn L GorePublished in: Cancer (2021)
This analysis of men on active surveillance for prostate cancer shows that approximately 1 in 10 men will decide to be treated within 4 years of their diagnosis even if their cancer is stable. These choices may be related in part to quality-or-life or spousal concerns.